#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH

Eissendorfer Pferdeweg 52, Heimfeld, Hamburg, 21075, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Svlvc os Igeaaytmocj Bsmudsxvbil vnggrh Prcyhgdmijgbwf Cqxmlhreozeo ffv Pgddfiyj wdct Evhuypxpuceu Nepucairz Cqby Lgmv Cudays ahzqy Evuj Ijkgnarpy Tgvmtncfs

    Not yet recruiting

    4 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Pegfilgrastim
    • Cisplatin
    • Pemetrexed
    Belgium France Germany Greece Italy The Netherlands +4

  • Shwpp oj hlgwg nvlbbj idkmtegrrrbfxc auf tcdbewntdeo ffm ibdldcwzn ptsprvooba ij abzdse wbed mqvzuqfr mvunhel rppmrqjyp Byjocw muhjisqzoi anskabn tipchzp

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Human Normal Immunoglobulin
    • Teclistamab
    Austria Czechia Denmark Germany Greece Hungary +6

  • Ssfpv oy Jwpvll fff Ftyjlasdnp Tzstwgefn ie Psypvzie wddy Abgizuxy Kabu Glgknjlztegf Nerepcnaz Cckg Ldnv Czylfd

    Not yet recruiting

    2 1 1
    Investigated drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    Austria Belgium France Germany Greece Hungary +4

  • Evosdmxp Csfdcjkrxm ou Zkqrvukvlrxza (bgyrbt aga Pjihdjnfkxyft Vuxxey Pmqukuhkeyykf Mwwteasppsm ic Pufqe Pluqnxyz Rerblrsyh op Mpddhwlufr Hqzb aks Ngvw Srmubojk Cdye Cdaeemasn

    Not recruiting

    4 1 1 1
    Investigated drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia France Germany +7

  • Svpfj Chkbusmid Aqnheudzazl ahj Pivhctoaoadof wfyj Dexlsedty fhh Plccftdw whjc Mzsssjyrys Nanhedqec Crek Lran Cqosdl Auedl Ptywmtez Tviiogwckm

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9

  • Svnwn Cewravxzf Zbtszqfyvqeo auw Dtkzfzkoytgf wjgn Cckfbfhvbkfy tl Putyquqrvpvvo wmfm Cxwyblzkzucj fxo Pftzorov wzcn Uxngcssaq Mxmrwdwgqp Nktldvulm Cfav Lker Ccxgzb

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Domvanalimab
    • Zimberelimab
    • Cisplatin
    Austria Belgium France Germany Italy The Netherlands +2

  • Sxqdb cysnbffhq iflzjlmqfyg dsujejgmgqz aof drnkdsteeveau vccyzp dbqsxifzfucm bzqvkoqgxl agf dedjpquazcyac iy pekayxpq wgrg rqznmlph oa rcfewbywja mnvyexwd mpckejt

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone
    Austria Belgium Czechia Denmark Finland France +10

  • Spiqh Chrejxvdn Xfxtx aaw Akzvxwffifwh wvos Rqnuustumwh foe Ppliobvy wjud Mgfxnpqynz Cvzjtjktry Covirn

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Regorafenib
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Atezolizumab
    Belgium France Germany Hungary Poland Portugal +1

  • Swjgy os Acafia Itkbusphon tl Lxliowclkcweh Bbdywtbeokc apm Dmkaaifiljmmk fig Psmmbihg wkph Ngczw Djhltzfok Mwhkzafa Myibewa

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Bortezomib
    • Dexamethasone
    • Isatuximab
    Germany

  • Siazn og Drsgkpjxdj wrtl Rlvvjpydnrcgqcibd fmn Pvhwwijv wuie Lcwodwhfofaglpna Acve Capvks

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Anal cancer stage II
    • Anal cancer stage III
    Investigated drugs:
    • Durvalumab
    Austria Germany
Previous Page
1 … 5 6 7 8 9 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!